Skip to main content
Skip to footer
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
Listing Regulation
Listing Regulation
Press Release
Active Biotech announces timetable for reverse share split
Press Release
Annual General Meeting of Active Biotech AB
Press Release
Active Biotech Interim Report Q1 2026
Press Release
NOTICE OF ANNUAL GENERAL MEETING
Press Release
Active Biotech Year End Report 2025
Press Release
Active Biotech’s nomination committee appointed
Press Release
Active Biotech announces outcome in the rights issue
Press Release
The subscription period in Active Biotech’s rights issue begins today
Press Release
Active Biotech publishes information document regarding rights issue
Press Release
Extraordinary General Meeting of Active Biotech AB
Show more
